Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date Sort ascending | Activity Code(s) | Title |
---|---|---|---|
PAR-24-152 | May 8, 2027 | R15 | Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
NOT-MH-24-115 | April 6, 2027 | R43/R44,R41/R42 | Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace |
PAR-24-131 | April 6, 2027 | R43/R44 | Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) |
PAR-24-132 | April 6, 2027 | R43/R44 | Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) |
PAR-24-133 | April 6, 2027 | R41/R42 | Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) |
PAR-24-134 | April 6, 2027 | R41/R42 | Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) |
RFA-MH-24-280 | February 9, 2027 | R01 | BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) |
RFA-NS-24-016 | January 29, 2027 | UG3/UH3 | BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
RFA-NS-24-031 | January 29, 2027 | R18 | BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) |
RFA-NS-24-017 | January 29, 2027 | UH3 | BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) |
RFA-NS-25-012 | January 16, 2027 | R61/R33 | HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) |
PAR-23-298 | January 8, 2027 | R01 | Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) |
NOT-OD-24-058 | January 8, 2027 | U24,R01,R21,R34,UG3/UH3,R03 | Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being |
PAR-23-285 | January 8, 2027 | R34 | Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) |
PAR-23-299 | January 8, 2027 | R21 | Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) |
PAR-24-059 | January 8, 2027 | R01 | Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) |
PA-24-141 | January 8, 2027 | R13 | NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
PAR-24-077 | January 8, 2027 | R01 | Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional) |
NOT-HL-23-117 | January 8, 2027 | R01 | Notice of Special Interest (NOSI): Palliative Care in the Care Continuum among Persons with Serious Heart, Lung, Blood and Sleep (HLBS) Diseases and their Caregivers |
RFA-NS-24-019 | January 8, 2027 | UG3/UH3 | HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) |